PC
EW icon

Pier Capital’s Edwards Lifesciences EW Stock Holding History

Pier Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,025
Closed -$278K – 112
2020
Q2 		$278K Buy
+4,025
New +$286K 0.04% 107
2016
Q4 		– Sell
-7,842
Closed -$315K – 122
2016
Q3 		$315K Sell
7,842
-11,490
-59% -$433K 0.06% 114
2016
Q2 		$643K Buy
19,332
+798
+4% +$27.3K 0.12% 107
2016
Q1 		$545K Sell
18,534
-6,345
-26% -$175K 0.11% 109
2015
Q4 		$655K Buy
24,879
+417
+2% +$10.8K 0.11% 105
2015
Q3 		$580K Buy
+24,462
New +$590K 0.09% 115

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pier Capital's EW Position: Q3 2020 in Review

Pier Capital sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 4,025 shares — an estimated $278K sold.

Pier Capital first reported a position in EW in Q3 2015 and held it in 6 quarters. The position peaked at $655K in Q4 2015. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Pier Capital reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • Pier Capital sold 4,025 Edwards Lifesciences shares in Q3 2020, an estimated $278K.
  • Pier Capital first reported a position in Edwards Lifesciences in Q3 2015 and held it in 6 quarters.
  • Pier Capital's Edwards Lifesciences position peaked at $655K in Q4 2015.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Pier Capital's 13F filing for Q3 2020, filed 13 Nov 2020.